The Fifth IFSO Global Registry Report (2019) has been released at the XXIV World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in Madrid, Spain. Published by Dendrite Clinical Systems, under the auspices of the IFSO, the publication reports data from more than 60 countries on over 833,000 operations including baseline obesity-related disease, operation types, operative outcomes and disease status after bariatric surgery.
Dendrite Clinical Systems has announced the installation of its National Bariatric Surgical Registry software at the Sheik Al Jaber Al Sabah Hospital, in Kuwait. The Sheik Al Jaber Al Sabah Hospital, opened by His Highness the Amir Sheikh Sabah Al-Ahmad Al- Jaber Al-Sabah in November 2018, consists of five towering 10-stories structures built on a 220,000 square meters and has a hospital bed capacity of around 1,160 with 36 operation rooms, a medical centre, a helipad and a parking lot accommodating some 5,000 vehicles.
Dendrite Clinical Systems and the Queen Mary Hospital in Hong Kong have launched the Asian Hypospadias Outcome Registry (AHOR), is a prospective web-based patient registry that will collect, record and analyse the treatment and outcomes of patients undergoing surgical repair.
Dendrite Clinical Systems has launched its ‘One-button push’ outcomes module, allowing clinicians to instantly produce their outcomes with the push of a single button. This enhancement is the latest in a series of advances incorporated into the company’s clinical registry software.
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 40 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems – in collaboration with Haemotology Cancer Care (UCLH Charity), the Royal Free Charity, HaemSTAR (an organisation researching non-malignant haematology) and MPN Voice – have launched the MASCOT (Myeloproliferative Neoplasm Splanchnic Vein Thrombosis, MPN-SVT) Registry, a UK wide registry for patients with myeloproliferative diseases suffering from splanchnic or abdominal vein thrombosis.
Dendrite Clinical Systems and The American Vein and Lymphatic Society (formerly the American College of Phlebology) are delighted to announce the launch of the American Vein and Lymphatic Society Registry - a ‘real-time’ clinical database that will identify practice patterns for venous and lymphatic disease diagnosis and treatment across North America.
The aim of the registry is to analyse the aggregate data and produce an annual publication that will outline important demographic features, risk factors, diagnostic characteristics, disease patterns, and treatment outcomes of venous and lymphatic disease within North America.
It is hoped that the Registry will assist the AVLS in developing standards of care and guideline documents for the treatment of various venous and lymphatic disease by improving the standards of medical practitioners, the quality of patient care and patient management.
The Registry will allow physicians to enter the demographics, risk factors, clinical features, management details and follow-up of all major venous and lymphatic diseases. Outcome reports (e.g. risk-factor distribution, indications, patency rates, and complication rates) will be available in real time and physicians will have the ability to compare them with the aggregated outcomes of all entries in the database. The Registry can be programmed to generate lists for pending follow-ups, letters to patients, and reminder emails to physicians.
The Registry is web-based and allows the individual clinician to enter patient information into the database from the hospital, an office-based practice, or even from home. Clinicians can add as many cases as they wish and where possible they will be encouraged to put on retrospective data (if available).
“We are thrilled to be part of this exciting project. The registry is the largest database of its kind specifically designed for venous and lymphatic disease and will be of tremendous educational value to the AVLS, its members and ultimately, patients,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “The Registry represents an important milestone for the company and reflects our expanding database portfolio.”
